Parallel import is present in many fields, from construction materials, clothing, food to medicinal products.
Parallel import is based on the principles of free movement of goods in EU/EES.
The prices of medicinal products differ among the EU member states, and this fact – combined with the basic EU/EES principles of the free movement of goods – create the basis for parallel import of medicines.
All distributed products must be approved by the national medicine regulatory authorities or by the European Medicines Agency (EMA).
We buy medicinal products from countries in which the price is low and sell them in countries where the price is higher, therefore our prices are always competitive with the prices charged by direct importers.
Parallel importing aims to reduce prices by introducing competition and therefore generate important savings for the patient.
We have the ability to do this, having access to original products from all over Europe and by doing this the pharmacists, the health insurance funds and the patients themselves, can benefit from.